TARGETED RADIONUCLIDE THERAPY OF MELANOMA: ANTI-TUMOURAL EFFICACY OF A NEW IODINE-131 LABELLED AGENT

被引：0
|
作者：
Bonnet, M. [1 ]
Papon, J. [1 ]
Mishellany, F. [2 ]
Labarre, P. [1 ]
Maublant, J. [3 ]
Penault-Llorca, F. [2 ]
Cayre, A. [2 ]
Miot-Noirault, E. [1 ]
Madelmont, J. [1 ]
Chezal, J. [1 ]
Moins, N. [1 ]
机构：
[1] Univ Auvergne, CJP, EA4231, Clermont Ferrand, France
[2] Ctr Jean Perrin, Anat Pathol Lab, Clermont Ferrand, France
[3] Ctr Jean Perrin, Nucl Med Serv, Clermont Ferrand, France
来源：
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS | 2009年 / 52卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：S95 / S95
页数：1
相关论文
共 50 条
  • [31] NEW IODINATED AND FLUORINATED RADIOTRACERS FOR PET/SPECT IMAGING AND TARGETED RADIONUCLIDE THERAPY OF MELANOMA
    Maisonial, A.
    Papon, J.
    Boisgard, R.
    Bonnet-Duquennoy, M.
    Kuhnast, B.
    Deloye, J.
    Askienazy, S.
    Maublant, J.
    Tavitian, B.
    Dolle, F.
    Madelmont, J.
    Moins, N.
    Chezal, J.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2009, 52 : S229 - S229
  • [32] Iodine-131 anti-B1 antibody therapy in non-Hodgkin's lymphoma: Dosimetry and clinical implications
    Wahl, RL
    JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (08) : 1S - 1S
  • [33] Synthesis and Evaluation of 131I-Skyrin as a Necrosis Avid Agent for Potential Targeted Radionuclide Therapy of Solid Tumors
    Wang, Cong
    Jin, Qaomei
    Yang, Shengwei
    Zhang, Dongjian
    Wang, Qin
    Li, Jindian
    Song, Shaoli
    Sun, Ziping
    Ni, Yicheng
    Zhang, Jian
    Yin, Zhiqi
    MOLECULAR PHARMACEUTICS, 2016, 13 (01) : 180 - 189
  • [34] Development of Lutebodies: a new class of targeted anti-cancer agents for radionuclide therapy
    Aerts, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S359 - S359
  • [35] Radiation dosimetry of [131I]ICF01012 in rabbits: Application to targeted radionuclide therapy for human melanoma treatment
    Jouberton, Elodie
    Perrot, Yann
    Dirat, Beatrice
    Billoux, Tommy
    Auzeloux, Philippe
    Cachin, Florent
    Chezal, Jean-Michel
    Filaire, Marc
    Labarre, Pierre
    Miot-Noirault, Elisabeth
    Millardet, Corinne
    Valla, Clemence
    Vidal, Aurelien
    Degoul, Francoise
    Maigne, Lydia
    MEDICAL PHYSICS, 2018, 45 (11) : 5251 - 5262
  • [36] Synthesis, Radiosynthesis, and In Vitro Evaluation of an Iodine-123 agent for Targeted Radionuclide Therapy of PARP-expressing Tumours
    Destro, G.
    Chen, Z.
    Chan, C.
    Dias, G.
    Fraser, C.
    Mosley, M.
    O'Neill, E.
    Gouverneur, V.
    Guibbal, F.
    Cornelissen, B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S436 - S436
  • [37] Autophagy inhibition improves the targeted radionuclide therapy efficacy of 131I-FAP-2286 in pancreatic cancer xenografts
    Liu, Xingyu
    Li, Danni
    Ma, Tianbao
    Luo, Xiu
    Peng, Ye
    Wang, Tao
    Zuo, Changjing
    Cai, Jianming
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [38] Autophagy inhibition improves the targeted radionuclide therapy efficacy of 131I-FAP-2286 in pancreatic cancer xenografts
    Xingyu Liu
    Danni Li
    Tianbao Ma
    Xiu Luo
    Ye Peng
    Tao Wang
    Changjing Zuo
    Jianming Cai
    Journal of Translational Medicine, 22
  • [39] Phase I study of [131 I] ICF01012, a targeted radionuclide therapy, in metastatic melanoma: MELRIV-1 protocol
    Thivat, Emilie
    Rouanet, Jacques
    Auzeloux, Philippe
    Sas, Nicolas
    Jouberton, Elodie
    Levesque, Sophie
    Billoux, Tommy
    Mansard, Sandrine
    Molnar, Ioana
    Chanchou, Marion
    Fois, Giovanna
    Maigne, Lydia
    Chezal, Jean-Michel
    Miot-Noirault, Elisabeth
    D'Incan, Michel
    Durando, Xavier
    Cachin, Florent
    BMC CANCER, 2022, 22 (01)
  • [40] Revised nuclear regulatory commission regulations for release of patients administered radioactive materials: Outpatient iodine-131 anti-B1 therapy
    Siegel, JA
    JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (08) : 28S - 33S
12345